Marker Therapeutics (MRKR) Interest Coverage Ratio (2010 - 2013)
Marker Therapeutics (MRKR) reported Interest Coverage Ratio of 3.33 for Q1 2013, up 52.06% year-over-year from 2.19 in Q1 2012, and up 89.36% quarter-over-quarter from 31.31 in Q2 2012.
Marker Therapeutics (MRKR) Interest Coverage Ratio (2010 - 2013) Analysis & Trends
Marker Therapeutics (MRKR) has 4 years of Interest Coverage Ratio data on file, last reported at 3.33 in Q1 2013.
- Interest Coverage Ratio for Q1 2013 came in at 3.33, up 52.06% year-over-year; the trailing twelve-month figure through Jun 2015 was 204.51 (changed N/A YoY), and the FY2015 annual result was 563.75, changed N/A from the prior year.
- Interest Coverage Ratio improved to 3.33 in Q1 2013 per MRKR's latest filing, from 31.31 in the prior quarter.
- Over five years, Interest Coverage Ratio peaked at 2.69 in Q3 2010 and troughed at 31.31 in Q2 2012.
- A 4-year average of 7.88 and a median of 6.0 in 2011 frame the typical range for Interest Coverage Ratio.
- The sharpest annual moves came in 2012 and 2013: Interest Coverage Ratio slumped 337.94% in 2012, then soared 52.06% in 2013.
- A 4-year view of Interest Coverage Ratio shows it stood at 2.97 in 2010, then slumped by 70.04% to 5.05 in 2011, then plunged by 520.26% to 31.31 in 2012, then soared by 89.36% to 3.33 in 2013.
- Business Quant data shows MRKR's Interest Coverage Ratio at 3.33 in Q1 2013, 31.31 in Q2 2012, and 6.95 in Q1 2012.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | - |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | 3.58 |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | -258.33 |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | 11.50 |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | 547.67 |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | - |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | 11.79 |
| 10 | Marker Therapeutics | 28.20 Mn | 28.20 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2013 | -3.33 |
| Jun 30, 2012 | -31.31 |
| Mar 31, 2012 | -6.95 |
| Dec 31, 2011 | -5.05 |
| Sep 30, 2011 | -8.72 |
| Jun 30, 2011 | -7.15 |
| Mar 31, 2011 | -3.08 |
| Dec 31, 2010 | -2.97 |
| Sep 30, 2010 | -2.69 |
| Jun 30, 2010 | -7.54 |